The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship between sarcopenia and dose-limiting toxicity (DLT) of sorafenib (SOR) in patients (pts) with advanced radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC) in the phase III DECISION trial.
 
Olivier Huillard
Consulting or Advisory Role - Astellas Pharma; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer; Roche/Genentech; Sanofi
 
Marcia S. Brose
Honoraria - Bayer; Exelixis; Onyx
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Onyx; Oxigene
Research Funding - Bayer (Inst); Eisai (Inst); Exelixis (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Onyx
 
Anne Jouinot
Travel, Accommodations, Expenses - Amgen; Pierre Fabre
 
Camille Tlemsani
No Relationships to Disclose
 
Jennifer ARRONDEAU
Honoraria - AstraZeneca
 
Gerold Meinhardt
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Marc Mardoche Fellous
Employment - Bayer
 
Yoriko De Sanctis
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Martin Schlumberger
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Sanofi
 
Francois Goldwasser
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Fresenius Kabi; Pfizer
Consulting or Advisory Role - Bayer; Fresenius Kabi
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Novartis